If GLP-1 inhibitors were a book, we would likely be in the second chapter. Used for almost two decades in the treatment of diabetes, the drugs have made the condition much more manageable for patients worldwide.
Arguably, they represent the first major pharmacological advancement towards preventing type 2 diabetes; a disease that threatens to cripple healthcare...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?